Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma

International Journal of Cancer(2020)10.1002/ijc.33046Source: DataRank Database

Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma is a research paper published in International Journal of Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 44 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access44 citations

Download PDF

Cite:

Linked data & code

cellosaurus doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: bronzeTopics (21)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Niveditha Nerlakanti ORCID,Chen Hao Lo ORCID,Marilena Tauro ORCID,Thomas J. Utset‐Ward ORCID,Damon R. Reed ORCID

Live enrichment

PubMed:32599665 PMC:PMC7787271

Comprehensive Cancer Center, City of Hope

Grant: P30‐CA076292

NIH HHS

Grant: P30-CA076292

NCI NIH HHS

Grant: P30 CA076292

Moffitt Cancer Center

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.33046

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.33046

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33046

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/ijc.33046

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7787271

MeSH Terms

Cell Line, TumorAnimalsHumansMiceOsteosarcomaBone NeoplasmsLung NeoplasmsDepsipeptidesSurvival AnalysisXenograft Model Antitumor AssaysCell ProliferationCell SurvivalGene Expression Regulation, NeoplasticHistone Deacetylase 1Histone Deacetylase 2Histone Deacetylase InhibitorsPanobinostat

Keywords

Histone deacetylaseOsteosarcomalung metastasisPanobinostat

Additional file 1 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598660.v1figshare

Additional file 1 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598660figshare

Additional file 2 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598663.v1figshare

Additional file 2 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598663figshare

Additional file 3 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598666.v1figshare

Additional file 3 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598666figshare

Additional file 5 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598672figshare

Additional file 4 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598669figshare

Additional file 5 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598672.v1figshare

Additional file 4 of The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer

10.6084/m9.figshare.22598669.v1figshare